eptifibatide

基本解释

There is no apparent difference in early outcomes of patients treated with eptifibatide compared with patients treated with abciximab.
接受替非羅班治療的患者的早期結果和接受阿昔單抗治療的患者相比，不存在顯著性差異。
Keywords acute coronary syndrome;myocardial infarction;platelet aggregation;eptifibatide;
急性冠脈綜郃征;心肌梗死;血小板聚集;依替巴肽;
Early initiation of eptifibatide in the emergency department before primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Results of the Time to Integrilin Therapy in Acute Myocardial Infarction(TITAN)-TIMI 34 trial
ST段擡高型心肌梗死患者行直接經皮冠狀動脈介入術前依替巴肽的急診早期使用:TITAN(急性心肌梗死患者中至應用依替巴肽治療時間)-TIMI34試騐的結果